NO20081617L - Metoder for fremstilling av Glutaminsyrederivater - Google Patents

Metoder for fremstilling av Glutaminsyrederivater

Info

Publication number
NO20081617L
NO20081617L NO20081617A NO20081617A NO20081617L NO 20081617 L NO20081617 L NO 20081617L NO 20081617 A NO20081617 A NO 20081617A NO 20081617 A NO20081617 A NO 20081617A NO 20081617 L NO20081617 L NO 20081617L
Authority
NO
Norway
Prior art keywords
preparation
glutamic acid
acid derivatives
methods
novel methods
Prior art date
Application number
NO20081617A
Other languages
English (en)
Inventor
Joseph Zeldis
David Michael Blum
Ronald Stanley Michalak
Mel Jennings
Timothy Doyle
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20081617L publication Critical patent/NO20081617L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Foreliggende oppfinnelse angår nye metoder for fremstilling av glutaminsyrederivater og mellomprodukter derav, og slike forbindelser fremstilt ved de nye metodene. 58
NO20081617A 2005-10-13 2008-04-02 Metoder for fremstilling av Glutaminsyrederivater NO20081617L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72644105P 2005-10-13 2005-10-13
PCT/US2006/026892 WO2007044100A1 (en) 2005-10-13 2006-07-11 Methods for preparing glutamic acid derivatives

Publications (1)

Publication Number Publication Date
NO20081617L true NO20081617L (no) 2008-05-06

Family

ID=37119907

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081617A NO20081617L (no) 2005-10-13 2008-04-02 Metoder for fremstilling av Glutaminsyrederivater

Country Status (18)

Country Link
US (1) US7541485B2 (no)
EP (1) EP1934171A1 (no)
JP (1) JP2009511578A (no)
KR (1) KR20080058436A (no)
CN (1) CN101282927A (no)
AR (1) AR057451A1 (no)
AU (1) AU2006299918A1 (no)
BR (1) BRPI0617348A2 (no)
CA (1) CA2624866A1 (no)
CR (1) CR9885A (no)
EC (1) ECSP088360A (no)
GT (1) GT200600305A (no)
IL (1) IL190729A0 (no)
NO (1) NO20081617L (no)
PE (1) PE20070526A1 (no)
RU (1) RU2008113222A (no)
TW (1) TW200740729A (no)
WO (1) WO2007044100A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR061420A1 (es) * 2006-06-02 2008-08-27 Wyeth Corp Metodos para preparar derivados de acido glutamico e intermediarios del mismo
US20100216886A1 (en) * 2006-11-09 2010-08-26 Wyeth Polymorphs of n2-(1,1'-biphenyl-4-ylcarbonyl)-n1-[2-(4-fluorophenyl)-1,1-dimethylethyl]-l-alpha-glutamine
ES2776106T3 (es) * 2011-09-30 2020-07-29 Kemira Oyj Prevención de la degradación de almidón en procesos fabricación de pulpa, papel o cartón
ES2968371T3 (es) 2013-10-10 2024-05-09 Eastern Virginia Medical School Derivados de 4-((2-hidroxi-3-metoxibencil)amino) bencenosulfonamida como inhibidores de la 12-lipoxigenasa
EP3286172B1 (en) 2015-04-23 2019-06-12 Constellation Pharmaceuticals, Inc. Lsd1 inhibitors and uses thereof
LT3532459T (lt) 2016-10-26 2023-11-10 Constellation Pharmaceuticals, Inc. Lsd1 inhibitoriai ir jų medicininis panaudojimas
US12668594B2 (en) 2020-12-23 2026-06-30 Sudo Biosciences Limited TYK2 inhibitors and uses thereof
IL305119A (en) 2021-02-19 2023-10-01 Sudo Biosciences Ltd Tyk2 inhibitors and uses thereof
TW202302583A (zh) 2021-02-19 2023-01-16 英商蘇多生物科學有限公司 Ｔｙｋ２抑制劑及其用途
KR20230159421A (ko) 2021-02-19 2023-11-21 수도 바이오사이언시즈 리미티드 Tyk2 억제제 및 이의 용도

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2440649A (en) 1948-04-27 Quinazoline
GB1108819A (en) 1964-07-31 1968-04-03 Rotta Research Lab Derivatives of 2-acylaminobicarboxylic acids and method for preparing same
DE3332633A1 (de) 1983-09-09 1985-04-04 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel
DE4102024A1 (de) 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5424334A (en) 1991-12-19 1995-06-13 G. D. Searle & Co. Peptide mimetic compounds useful as platelet aggregation inhibitors
CA2150550A1 (en) 1992-12-01 1994-06-09 Melissa S. Egbertson Fibrinogen receptor antagonists
JPH06192199A (ja) 1992-12-25 1994-07-12 Mitsubishi Kasei Corp ケトン誘導体
US5563127A (en) 1993-03-24 1996-10-08 The Dupont Merck Pharmaceutical Company Boronic acid and ester inhibitors of thrombin
DE69530683T2 (de) 1994-03-11 2004-03-25 Pharmacopeia, Inc. Sulfonamid derivate und deren verwendung
GB2292149A (en) 1994-08-09 1996-02-14 Ferring Res Ltd Peptide inhibitors of pro-interleukin-1beta converting enzyme
US6306840B1 (en) 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
KR19990035780A (ko) 1995-07-24 1999-05-25 후지야마 아키라 Ｐｌａ２ 억제제로서의 에스테르 및 아미드
EP0910564B1 (en) 1995-11-28 2007-10-31 Cephalon, Inc. D-amino acid derived inhibitors of cysteine and serine proteases
DE69833858T2 (de) 1997-07-08 2007-02-22 Ono Pharmaceutical Co. Ltd. Aminosäurederivate
JP4129069B2 (ja) 1997-09-16 2008-07-30 株式会社Ａｄｅｋａ アシル化ペプチド類の製造方法
JP4090541B2 (ja) 1997-10-15 2008-05-28 株式会社Ａｄｅｋａ アシル化ペプチド類の製造方法
WO1999048371A1 (en) 1998-03-27 1999-09-30 The Regents Of The University Of California Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors
TWI245035B (en) 1998-06-26 2005-12-11 Ono Pharmaceutical Co Amino acid derivatives and a pharmaceutical composition comprising the derivatives
US6242422B1 (en) 1998-10-22 2001-06-05 Idun Pharmacueticals, Inc. (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
US7157430B2 (en) 1998-10-22 2007-01-02 Idun Pharmaceuticals, Inc. (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases
DE19851184A1 (de) 1998-11-06 2000-05-11 Aventis Pharma Gmbh N-Arylsulfonyl-aminosäure-omega-amide
US6265610B1 (en) * 1999-01-12 2001-07-24 The University Of North Carolina At Chapel Hill Contrast media for angiography
US6723711B2 (en) 1999-05-07 2004-04-20 Texas Biotechnology Corporation Propanoic acid derivatives that inhibit the binding of integrins to their receptors
SK288186B6 (sk) 1999-05-07 2014-05-06 Encysive Pharmaceuticals, Inc. Deriváty kyseliny propiónovej, ktoré inhibujú väzbu integrínov na ich receptory, farmaceutické kompozície s ich obsahom a ich použitie
US6493791B1 (en) * 1999-12-20 2002-12-10 Intel Corporation Prioritized content addressable memory
WO2001083445A1 (en) 2000-04-25 2001-11-08 Samsung Electronics Co., Ltd. Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
US6723733B2 (en) 2000-05-19 2004-04-20 Guilford Pharmaceuticals, Inc. Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses
CA2321348A1 (en) * 2000-09-27 2002-03-27 Blaise Magloire N'zemba Aromatic derivatives with hiv integrase inhibitory properties
JP2002145849A (ja) 2000-11-10 2002-05-22 Kyorin Pharmaceut Co Ltd アルキニルアミノ酸誘導体及びその製造法
US20050049242A1 (en) 2000-12-21 2005-03-03 W. Edward Robinson Novel HIV integrase inhibitors and HIV therapy based on drug combinations including integrase inhibitors
US20040009956A1 (en) 2002-04-29 2004-01-15 Dehua Pei Inhibition of protein tyrosine phosphatases and SH2 domains by a neutral phosphotyrosine mimetic
US7514438B2 (en) 2003-08-13 2009-04-07 Amgen, Inc. Melanin concentrating hormone receptor antagonist
US20070208166A1 (en) 2003-10-24 2007-09-06 Exelixis, Inc. Tao Kinase Modulators And Method Of Use
BR0318625A (pt) 2003-12-04 2006-10-31 Wyeth Corp biaril sulfonamidas e métodos para usar as mesmas
CA2549598A1 (en) 2003-12-15 2005-06-30 Japan Tobacco Inc. N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
JP2007528404A (ja) 2004-03-09 2007-10-11 エラン ファーマシューティカルズ，インコーポレイテッド 置換された尿素およびカルバメート、フェナシル−２−ヒドロキシ−３−ジアミノアルカン、ならびにベンズアミド−２−ヒドロキシ−３−ジアミノアルカン系のアスパラギン酸プロテアーゼ阻害薬
MY144590A (en) 2005-07-11 2011-10-14 Wyeth Corp Glutamate aggrecanase inhibitors
DE102006018250A1 (de) 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Verfahren zum Herstellen von cyclischen Depsipeptiden
AR061420A1 (es) * 2006-06-02 2008-08-27 Wyeth Corp Metodos para preparar derivados de acido glutamico e intermediarios del mismo

Also Published As

Publication number Publication date
ECSP088360A (es) 2008-05-30
CN101282927A (zh) 2008-10-08
WO2007044100A1 (en) 2007-04-19
JP2009511578A (ja) 2009-03-19
RU2008113222A (ru) 2009-11-20
US20070088172A1 (en) 2007-04-19
IL190729A0 (en) 2008-11-03
CA2624866A1 (en) 2007-04-19
PE20070526A1 (es) 2007-06-11
AR057451A1 (es) 2007-12-05
US7541485B2 (en) 2009-06-02
GT200600305A (es) 2007-02-26
CR9885A (es) 2008-06-16
TW200740729A (en) 2007-11-01
AU2006299918A1 (en) 2007-04-19
EP1934171A1 (en) 2008-06-25
BRPI0617348A2 (pt) 2011-07-26
KR20080058436A (ko) 2008-06-25

Similar Documents

Publication Publication Date Title
CY1112402T1 (el) Ενισχυτες υποδοχεων γλουταμικου
WO2006092213A8 (de) Pyrazolylcarboxanilide
NO20074093L (no) Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav
NO20073678L (no) Nye fremgangsmater for fremstilling av benzofuran
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
EA200800321A1 (ru) Ингибиторы гистондеацетилазы
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
ATE362932T1 (de) Azaindolverbindungen als kinaseinhibitoren
CY1109055T1 (el) 11-((4r,6r)-4,5,6-τριϋδροξυ-3-(r)-υδροξυ-εξυλοκαρβαμοϋλο)-ενδεκαϊνικο οξυ
EA201070804A1 (ru) (аза)индольное производное, замещенное по положению 5, содержащая его фармацевтическая композиция, промежуточные соединения и способ их получения
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
NO20081621L (no) Tetrahydrokinoliner, syntese og intermediater
ECSP088360A (es) Métodos para preparar derivados de ácido glutámico
NO20080468L (no) Diazepinokinoliner, synteser av disse samt intermediater
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
ATE411994T1 (de) Herstellung eines substituierten chinoxalins von hoher reinheit
WO2009001203A3 (en) An improved process for the preparation of aprepitant
NO20084839L (no) Metoder for fremstilling av glutaminsyrederivater og melomprodukter
DK1831239T5 (da) Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-gamma-lacton og nøgle-mellemprodukter til denne fremgangsmåde
DK1877370T3 (da) Fremgangsmåde til fremstilling af hydrazon-derivater
ES2333026T3 (es) Derivados de ciclohexil-1,4-diamina sustituidos.
EA200801549A1 (ru) Новые производные фенантридина в качестве антагонистов брадикинина
EA200702428A1 (ru) Способы получения 4-бифенилилазетидин-2-онов

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application